ASCO® 2024 Insights: "3Yr Follow-Up of RATIONALE-306 - Tislelizumab + Chemo vs. Placebo + Chemo as 1L Treatment for Advanced/Metastatic Esophageal SCC"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "3Yr Follow-Up of RATIONALE-306 - Tislelizumab + Chemo vs. Placebo + Chemo as 1L Treatment for Advanced/Metastatic Esophageal SCC"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Harry Yoon

144 views

June 6, 2024

Comments 0

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

2024 ASCO® Annual Meeting Insights Hub: GI Videos

ASCO® 2024 Insights: "Botensilimab + Balstilimab in Microsatellite S…

2024 ASCO® Annual Meeting Insights Hub

A. Bullock

125 views

3 months ago

ASCO® 2024 Insights: "Biomarker-Directed Treatment for Pancreatic Ad…

2024 ASCO® Annual Meeting Insights Hub

J. Knox

164 views

4 months ago

ASCO® 2024 Summary: "Fruquintinib in Refractory mCRC"

2024 ASCO® Annual Meeting Insights Hub

C. Eng

203 views

4 months ago

View All

Recent Updates in Upper Gl Cancers

Integrity CE

S. Mukherjee

336 views

3 months ago

ASCO® 2024 Summary: "Expert Panel Discussion on Upper-GI Cancers Inc…

2024 ASCO® Annual Meeting Insights Hub

N. Uboha, A. Turk, K. Spencer, M. Cecchini

537 views

5 months ago

Year in Review: Upper GI Cancers

Moffitt Cancer Center

R. Kim, R. Mehta

1.1K views

11 months ago

Opus One: Final Results - RFA in Axial Skeleton

Jason Levy

2.0K views

1 year ago

Overview of Esophageal & Gastric Cancer Diagnosis & Staging

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

V. Shankaran

204 views

4 months ago

ESMO 2024 Insights: DESTINY-Gastric03 - T-DXd Monotherapy and Combin…

2024 ESMO Annual Meeting Insights Hub

Y. Janjigian

125 views

1 month ago

ASCO® GI 2024 Summary: "Esophageal Squamous Cell Carcinoma Key Studi…

Insights from 2024 ASCO® GI Annual Meeting

R. Kim, R. Mehta

438 views

9 months ago

Gastroesophageal Cancer Updates From 2024 Summer Conferences

Debbie's Dream Foundation

S. Klempner

153 views

2 months ago

UChicago Medicine Best of ASCO® 2024: Upper GI & Pancreatic Cancers

UChicago Medicine Annual Practice Updates in Hematology and Oncology

M. Amin

139 views

2 months ago

GI Cancer Updates: The Role of Surgery After Neoadjuvant Systemic Th…

Yale Cancer Center

C. Balch

343 views

7 months ago

ASCO® 2024 Summary: "Latest Practice-Changing Data in Gastroesophage…

COR2ED The Heart of Medical Education

E. Smyth, S. Klempner, J. Seligmann, D. Modest

190 views

4 months ago

ESMO 2024 Insights: EPOC2001 Study - Lenvatinib + Pembro + FLOT in N…

2024 ESMO Annual Meeting Insights Hub

A. Kawazoe

150 views

1 month ago

Controversies in the Predictive Value of PD-L1 for Anti-PD-1 Benefit…

Elizabeth Smyth

R. Sundar

241 views

6 months ago

MRD in GI Malignancies: Current Clinical Utility of ctDNA

Horizon CME

A. Scott

201 views

5 months ago

ASCO® 2024 Summary: "Latest Practice-Changing Data in Breast Cancer,…

COR2ED The Heart of Medical Education

M. Socinski, P. R. Galle, S. Dawood, E. Smyth, S. Klempner

173 views

4 months ago

1L Therapy for Stage 4 Gastroesophageal Cancers: The Role of Biomark…

Hope for Stomach Cancer

D. Catenacci

359 views

11 months ago

Year in Review - Systemic Therapies for Metastatic Gastroesophageal …

Yale Cancer Center

J. Lacy

125 views

4 months ago

ASCO® GI 2024 Panel Discussion: "SKYSCRAPER-08 Clinical Implications…

Insights from 2024 ASCO® GI Annual Meeting

Y. Janjigian, S. Cytryn, S. Klempner

233 views

9 months ago

ASCO® 2024 Summary: "Updates in Frontline Management of GE Cancers -…

2024 ASCO® Annual Meeting Insights Hub

R. Sundar

126 views

4 months ago

ASCO® 2024 Review: Updates in the Management of Resectable Esophagea…

Nebraska Oncology Society

R. Safyan

94 views

3 months ago

AUTOPLAY

Login

Login

Join VuMedi

ASCO® 2024 Insights: "3Yr Follow-Up of RATIONALE-306 - Tislelizumab + Chemo vs. Placebo + Chemo as 1L Treatment for Advanced/Metastatic Esophageal SCC"

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

2024 ASCO® Annual Meeting Insights Hub: GI Videos

ASCO® 2024 Insights: "Botensilimab + Balstilimab in Microsatellite S…

ASCO® 2024 Insights: "Biomarker-Directed Treatment for Pancreatic Ad…

ASCO® 2024 Summary: "Fruquintinib in Refractory mCRC"

Recommended

Recent Updates in Upper Gl Cancers

ASCO® 2024 Summary: "Expert Panel Discussion on Upper-GI Cancers Inc…

Year in Review: Upper GI Cancers

Opus One: Final Results - RFA in Axial Skeleton

Overview of Esophageal & Gastric Cancer Diagnosis & Staging

ESMO 2024 Insights: DESTINY-Gastric03 - T-DXd Monotherapy and Combin…

ASCO® GI 2024 Summary: "Esophageal Squamous Cell Carcinoma Key Studi…

Gastroesophageal Cancer Updates From 2024 Summer Conferences

UChicago Medicine Best of ASCO® 2024: Upper GI & Pancreatic Cancers

GI Cancer Updates: The Role of Surgery After Neoadjuvant Systemic Th…

ASCO® 2024 Summary: "Latest Practice-Changing Data in Gastroesophage…

ESMO 2024 Insights: EPOC2001 Study - Lenvatinib + Pembro + FLOT in N…

Controversies in the Predictive Value of PD-L1 for Anti-PD-1 Benefit…

MRD in GI Malignancies: Current Clinical Utility of ctDNA

ASCO® 2024 Summary: "Latest Practice-Changing Data in Breast Cancer,…

1L Therapy for Stage 4 Gastroesophageal Cancers: The Role of Biomark…

Year in Review - Systemic Therapies for Metastatic Gastroesophageal …

ASCO® GI 2024 Panel Discussion: "SKYSCRAPER-08 Clinical Implications…

ASCO® 2024 Summary: "Updates in Frontline Management of GE Cancers -…

ASCO® 2024 Review: Updates in the Management of Resectable Esophagea…